Cargando…

Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry

IMPORTANCE: Chronic kidney disease (CKD) is serious and common, yet recognition and public health responses are limited. OBJECTIVE: To describe clinical features of, prevalence of, major risk factors for, and care for CKD among patients treated in 2 large US health care systems. DESIGN, SETTING, AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuttle, Katherine R., Alicic, Radica Z., Duru, O. Kenrik, Jones, Cami R., Daratha, Kenn B., Nicholas, Susanne B., McPherson, Sterling M., Neumiller, Joshua J., Bell, Douglas S., Mangione, Carol M., Norris, Keith C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991307/ https://www.ncbi.nlm.nih.gov/pubmed/31860111 http://dx.doi.org/10.1001/jamanetworkopen.2019.18169

Ejemplares similares

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019)

Use of Glucose-Lowering Agents in Diabetes and CKD
por: Alicic, Radica Z., et al.
Publicado: (2022)

Medication use, renin–angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney disease
por: Neumiller, Joshua J, et al.
Publicado: (2020)

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease
por: Alicic, Radica Z., et al.
Publicado: (2023)

WCN23-1183 DISPARITIES IN CHRONIC KIDNEY DISEASE RISKS: DATA FROM THE CURE-CKD COVID-19 REGISTRY
por: Nicholas, S., et al.
Publicado: (2023)

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors
por: Neumiller, Joshua J, et al.
Publicado: (2022)

Erratum. Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248–257
por: Alicic, Radica Z., et al.
Publicado: (2019)

Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization
por: Burley, Mason H., et al.
Publicado: (2016)

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney
por: Tuttle, Katherine R., et al.
Publicado: (2021)

Association between industry payments and prescriptions of long-acting insulin: An observational study with propensity score matching
por: Inoue, Kosuke, et al.
Publicado: (2021)

Patient Activation, Depressive Symptoms, and Self-Rated Health: Care Management Intervention Effects among High-Need, Medically Complex Adults
por: Corbett, Cynthia F., et al.
Publicado: (2021)

Educational Attainment, Decision-Making Preferences, and Interest in Evidence-Based Diabetes Prevention among Women with a History of Gestational Diabetes Mellitus
por: Panchal, Hemali, et al.
Publicado: (2021)

The Association of Depression and the Cardiovascular Risk Factors of Blood Pressure, HbA1c, and Body Mass Index among Patients with Diabetes: Results from the Translating Research into Action for Diabetes Study
por: Kimbro, Lindsay B., et al.
Publicado: (2012)

Effect of a community-based diabetes self-management empowerment program on mental health-related quality of life: a causal mediation analysis from a randomized controlled trial
por: Sugiyama, Takehiro, et al.
Publicado: (2015)

The impact of Dual Eligible Special Need Plan regulations on healthcare utilization
por: Narain, Kimberly Danae Cauley, et al.
Publicado: (2021)

Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths
por: Dieter, Brad P., et al.
Publicado: (2015)

The Diabetes Health Plan and Healthcare Utilization Among Beneficiaries with Low Incomes
por: Narain, Kimberly Danae Cauley, et al.
Publicado: (2022)

Association of Type 2 Diabetes Risk Perception With Interest in Diabetes Prevention Strategies Among Women With a History of Gestational Diabetes
por: Vu, Amanda, et al.
Publicado: (2022)

The diabetes health plan and medication adherence among individuals with low incomes
por: Narain, Kimberly Danae Cauley, et al.
Publicado: (2022)

Entering and Exiting the Medicare Part D Coverage Gap: Role of Comorbidities and Demographics
por: Ettner, Susan L., et al.
Publicado: (2010)

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement
por: Yala, Stella M, et al.
Publicado: (2014)

Differences in Weight Loss by Race and Ethnicity in the PRIDE Trial: a Qualitative Analysis of Participant Perspectives
por: Saju, Rintu, et al.
Publicado: (2022)

Time to start addressing (and not just describing) the social determinants of diabetes: results from the NEXT-D 2.0 network
por: Siegel, Karen R, et al.
Publicado: (2021)

Travel Burden and the Direct Medical Costs of Urologic Surgery
por: Olson, Daniel J., et al.
Publicado: (2016)

High-cost high-need patients in Medicaid: segmenting the population eligible for a national complex case management program
por: Quinton, Jacob K., et al.
Publicado: (2021)

3256 Effectiveness of Shared Decision-Making for Diabetes Prevention: 12-month Results from the Prediabetes Informed Decision and Education (PRIDE) Randomized Trial
por: Moin, Tannaz, et al.
Publicado: (2019)

The Landscape of Diabetic Kidney Disease in the United States
por: Duru, O. Kenrik, et al.
Publicado: (2018)

Chronic Kidney Disease, Queensland (CKD.QLD) Registry: Management of CKD With Telenephrology
por: Venuthurupalli, Sree K., et al.
Publicado: (2018)

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia
por: Venuthurupalli, Sree K., et al.
Publicado: (2017)

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021)

COVID-19 and Gastrointestinal Tract Symptoms: Recognition, Containment, and Learning From the Past
por: McDermott, Carmen V., et al.
Publicado: (2020)

In Reply — Neutralization of Fecal Aerosol-Laden SARS CoV-2: Public Health Implications
por: McDermott, Carmen V., et al.
Publicado: (2021)

Evaluation of the Diabetes Health Plan to Improve Diabetes Care and Prevention
por: Duru, O. Kenrik, et al.
Publicado: (2013)

Does the diabetes health plan have a differential impact on medication adherence among beneficiaries with fewer financial resources?
por: Huang, Cher X, et al.
Publicado: (2022)

Diabetes Prevention Program attendance is associated with improved patient activation: Results from the Prediabetes Informed Decisions and Education (PRIDE) study
por: Skrine Jeffers, Kia, et al.
Publicado: (2019)

Results from NEXT-D: the association of a pre-diabetes-specific health plan and rates of incident diabetes among a national sample of working-age adults
por: Moin, Tannaz, et al.
Publicado: (2020)

Association of the Diabetes Health Plan with emergency room and inpatient hospital utilization: a Natural Experiment for Translation in Diabetes (NEXT-D) Study
por: Moin, Tannaz, et al.
Publicado: (2021)

The association of a diabetes-specific health plan with ER and inpatient hospital utilization: a natural experiment for translation in diabetes (NEXT-D)
por: Moin, Tannaz, et al.
Publicado: (2015)

A randomized controlled trial of a shared decision making intervention for diabetes prevention for women with a history of gestational diabetes mellitus: The Gestational diabetes Risk Attenuation for New Diabetes (GRAND study)
por: Madievsky, Ruth, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4cia6sfedvabeq7u2iip6noo8c